semaglutide cancer study Disproportionality analysis of semaglutide-associated bile-duct cancer: A vigibase | Indian Journal of Gastroenterology GLP-1 Weight Loss Drugs May

Development and validation of a 30-item short adaptation of the mood and anxiety symptoms questionnaire (MASQ)

At Week 56, treatment with SAXENDA resulted in statistically significant reduction in BMI SDS from baseline compared to placebo

One trial involving six courses of Epithalamin over three years demonstrated decelerated cardiovascular aging, preserved physical endurance, normalized circadian melatonin rhythm, and improved carbohydrate and lipid metabolism

Altitude Drinks consumed at high altitudes are nearly twice as potent in their effect for the first few days until the person becomes accustomed to the elevation